Mismatch Repair Cancer Syndrome

Last updated: February 8, 2026Reviewed date: February 8, 2026Reading time: 23 min read
Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

Patient Mode

Understand this article easily

Switch between simple English and easy Bangla patient notes. This is for education and does not replace a doctor consultation.

Mismatch repair cancer syndrome (MMRCS), also known as Turcot syndrome or constitutional mismatch repair-deficiency (CMMRD) syndrome when referring to biallelic mutations, is a rare inherited disorder marked by a greatly increased risk of multiple cancers, often beginning in childhood. In MMRCS, both copies of one...

For severe symptoms, danger signs, pregnancy, child illness, or sudden worsening, seek urgent medical care.

বাংলা রোগী নোট এখনো যোগ করা হয়নি। পোস্ট এডিটরে “RX Bangla Patient Mode” বক্স থেকে সহজ বাংলা সারাংশ যোগ করুন।

এই তথ্য শিক্ষা ও সচেতনতার জন্য। এটি ডাক্তারি পরীক্ষা, রোগ নির্ণয় বা প্রেসক্রিপশনের বিকল্প নয়।

Article Summary

Mismatch repair cancer syndrome (MMRCS), also known as Turcot syndrome or constitutional mismatch repair-deficiency (CMMRD) syndrome when referring to biallelic mutations, is a rare inherited disorder marked by a greatly increased risk of multiple cancers, often beginning in childhood. In MMRCS, both copies of one of the DNA mismatch repair (MMR) genes—MLH1, MSH2, MSH6, or PMS2—harbor pathogenic variants, preventing normal correction of DNA replication errors....

Key Takeaways

  • This article explains Types of Mismatch Repair Cancer Syndrome in simple medical language.
  • This article explains Causes in simple medical language.
  • This article explains Symptoms in simple medical language.
  • This article explains Diagnostic Tests in simple medical language.
Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.

Seek urgent medical care if you notice

These warning signs are general safety guidance. Local emergency numbers and clinical judgment should always come first.

  • Severe symptoms, breathing difficulty, fainting, confusion, or rapidly worsening illness.
  • New weakness, severe pain, high fever, or symptoms after a serious injury.
  • Any symptom that feels urgent, unusual, or unsafe for the patient.
1

Emergency now

Use emergency care for severe, sudden, rapidly worsening, or life-threatening symptoms.

2

See a doctor

Book a professional medical evaluation if symptoms persist, worsen, recur often, affect daily activities, or occur in a high-risk patient.

3

Learn safely

Use this article to understand possible causes, tests, treatment options, prevention, and questions to ask your clinician.

Before reading

RX Patient Tools

Use these quick guides before reading the article, or return to them when you need help preparing questions for a doctor.

Start here Choose the right pathway for symptoms, reports, medicines, or urgent warning signs. Disease article roadmap Read this topic step by step: meaning, symptoms, warning signs, diagnosis, treatment, prevention, and follow-up. Treatment planner Prepare questions about treatment choices, benefits, risks, side effects, and follow-up. Family & caregiver guide Organize symptoms, reports, medicines, questions, and follow-up safely. Nutrition & diet guide Prepare food, hydration, supplement, and medicine-timing questions safely. Prevention guide Organize risk factors, protective habits, screening, and warning signs. Recovery guide Prepare a safe plan for activity, rehabilitation, warning signs, and follow-up.
Definition

Mismatch repair cancer syndrome (MMRCS), also known as Turcot syndrome or constitutional mismatch repair-deficiency (CMMRD) syndrome when referring to biallelic mutations, is a rare inherited disorder marked by a greatly increased risk of multiple cancers, often beginning in childhood. In MMRCS, both copies of one of the DNA mismatch repair (MMR) genes—MLH1, MSH2, MSH6, or PMS2—harbor pathogenic variants, preventing normal correction of DNA replication errors. As a result, affected individuals develop polyps in the large intestine and malignant tumors in the central nervous system (especially gliomas), often concurrently or sequentially. Beyond colorectal polyps and brain tumors, patients with MMRCS/CMMRD face high risks of leukemias, lymphomas, small-intestinal cancers, urinary tract cancers, sarcomas, and other malignancies. Features mimicking neurofibromatosis type 1—such as café-au-lait spots—along with developmental venous anomalies on imaging, are common benign signs. Lifespan is typically shortened, with many individuals developing a first cancer by age 10 and a second by late adolescence if untreated. medlineplus.goven.wikipedia.org

Types of Mismatch Repair Cancer Syndrome

  1. PMS2-associated CMMRD
    Pathogenic variants in the PMS2 gene account for over half of CMMRD cases. PMS2 encodes a protein critical for correcting small insertion–deletion loops; loss leads to severe genomic instability and early-onset tumors. medlineplus.gov

  2. MSH6-associated CMMRD
    Approximately 20% of patients carry biallelic MSH6 mutations. MSH6 partners with MSH2 to recognize base–base mismatches; its deficiency predisposes predominantly to hematologic and brain cancers in childhood. medlineplus.gov

  3. MLH1-associated CMMRD
    Biallelic MLH1 variants underlie a smaller subset of cases. MLH1 forms a complex with PMS2 to execute repair; its loss yields early colorectal polyposis and high-grade gliomas. medlineplus.gov

  4. MSH2-associated CMMRD
    Mutations in MSH2 comprise the remaining cases. As a key mismatch sensor, MSH2 deficiency presents similarly to MLH1-CMMRD but may also involve additional extracolonic tumors. medlineplus.gov

Causes

  1. Germline MLH1 Mutation
    An inherited change in both copies of the MLH1 gene impairs DNA repair, driving early tumor formation. medlineplus.gov

  2. Germline MSH2 Mutation
    Biallelic defects in MSH2 prevent mismatch recognition, leading to accumulation of replication errors and cancer. medlineplus.gov

  3. Germline MSH6 Mutation
    Dual MSH6 variants weaken repair of single-base mismatches, predisposing to lymphomas and gliomas. medlineplus.gov

  4. Germline PMS2 Mutation
    Homozygous PMS2 mutations eliminate repair of insertion–deletion loops, causing early colorectal polyp growth. medlineplus.gov

  5. Compound Heterozygosity
    Two different pathogenic variants in the same MMR gene (one from each parent) compromise protein function. medlineplus.gov

  6. Splice-Site Variants
    Mutations disrupting normal RNA splicing of MMR genes yield truncated, nonfunctional proteins. medlineplus.gov

  7. Nonsense Mutations
    Premature stop codons in MMR genes generate truncated proteins lacking repair domains. medlineplus.gov

  8. Frameshift Mutations
    Insertions or deletions shift the reading frame, producing aberrant MMR proteins. medlineplus.gov

  9. Large Genomic Deletions
    Loss of entire exons or whole MMR genes abolishes repair capacity. medlineplus.gov

  10. Missense Variants
    Single amino-acid changes destabilize MMR proteins or disrupt key interactions. medlineplus.gov

  11. Founder Mutations
    Population-specific variants (e.g., in Quebec’s Nunavik) cause “attenuated” CMMRD with later-onset cancers. medlineplus.gov

  12. Parental Carrier Status
    When both parents carry a single MMR gene variant (Lynch syndrome), each child has a 25% chance of CMMRD. medlineplus.gov

  13. Consanguinity
    Related parents increase the probability of inheriting identical pathogenic MMR gene copies. medlineplus.gov

  14. EPCAM Deletions
    Rare deletions upstream of MSH2 lead to its epigenetic silencing, mimicking biallelic loss. medlineplus.gov

  15. Somatic Second Hits
    Inherited monoallelic carriers may acquire a second somatic mutation, transitioning to full CMMRD in a specific tissue. medlineplus.gov

  16. Epigenetic Silencing
    Promoter hypermethylation of MLH1 in germ cells can act like a mutation, reducing gene expression. medlineplus.gov

  17. Mosaicism
    Postzygotic MMR gene mutations in early embryogenesis yield mosaic CMMRD, with variable tumor risk. medlineplus.gov

  18. Copy-Number Variations
    Gene duplications or losses affecting MMR loci disrupt normal protein dosage. medlineplus.gov

  19. Functional Hypomorphic Variants
    Partial‐function mutations allow some repair but still raise cancer risk. medlineplus.gov

  20. Unknown Modifier Genes
    Other genetic factors may influence CMMRD presentation and age of onset. medlineplus.gov

Symptoms

  1. Multiple Colorectal Polyps
    Dozens of benign growths in the large intestine appear often before age 10. medlineplus.gov

  2. Early-Onset Colorectal Cancer
    Malignant transformation of polyps leads to colon or rectal cancer in childhood or adolescence. medlineplus.gov

  3. High-Grade Gliomas
    Aggressive brain tumors arise, causing headaches, seizures, or focal neurologic deficits. medlineplus.gov

  4. Glioblastoma Multiforme
    A specific, highly malignant glioma subtype leads to rapid neurologic decline. medlineplus.gov

  5. Acute Lymphoblastic Leukemia (ALL)
    T-cell or B-cell ALL presents with fatigue, bruising, and bone pain. medlineplus.gov

  6. Non-Hodgkin Lymphoma
    Swollen lymph nodes, fever, and weight loss indicate lymphoma in children. medlineplus.gov

  7. Small-Intestinal Cancer
    Abdominal pain, obstruction, or bleeding may signal tumors in the small bowel. medlineplus.gov

  8. Urinary Tract Tumors
    Hematuria and pain can occur with bladder or ureteral cancers in teens. medlineplus.gov

  9. Endometrial Cancer
    In adolescent girls, abnormal uterine bleeding may reflect early endometrial carcinoma. medlineplus.gov

  10. Ovarian Tumors
    Pelvic pain or mass effect may indicate ovarian cancer in teenage girls. medlineplus.gov

  11. Sarcomas
    Bone or connective tissue tumors present with localized pain or swelling. medlineplus.gov

  12. Café-au-Lait Spots
    Multiple light-brown skin patches mimic neurofibromatosis type 1. medlineplus.gov

  13. Hypopigmented Macules
    Lighter skin patches often accompany café-au-lait spots. medlineplus.gov

  14. Developmental Venous Anomalies
    Venous malformations in the brain appear on MRI without symptoms. medlineplus.gov

  15. Growth Retardation
    Chronic illness and multiple cancers impair normal growth. medlineplus.gov

  16. Anemia
    Blood loss from polyps or marrow infiltration causes fatigue and pallor. medlineplus.gov

  17. Weight Loss
    Cancer-related metabolic changes lead to unintentional weight loss. medlineplus.gov

  18. Neurologic Deficits
    Seizures, vision changes, or motor weakness accompany brain tumors. medlineplus.gov

  19. Abdominal Pain
    Obstruction or tumor growth in the GI tract triggers crampy pain. medlineplus.gov

  20. Bleeding
    GI bleeding from polyps or tumors leads to melena or hematochezia. medlineplus.gov

Diagnostic Tests

Physical Exam

  1. General Inspection
    Look for café-au-lait spots, skin hypopigmentation, and growth milestones. medlineplus.gov

  2. Abdominal Palpation
    Assess for masses or pain when an area is touched or pressed. সহজ বাংলা: চাপ দিলে ব্যথা।" data-rx-term="tenderness" data-rx-definition="Tenderness means pain when an area is touched or pressed. সহজ বাংলা: চাপ দিলে ব্যথা।">tenderness from intestinal tumors. medlineplus.gov

  3. Neurologic Examination
    Evaluate cranial nerves, motor strength, and reflexes for brain tumor signs. medlineplus.gov

  4. Lymph Node Palpation
    Check for lymphadenopathy suggestive of lymphoma. medlineplus.gov

  5. Skin Examination
    Document café-au-lait and hypopigmented macules. medlineplus.gov

  6. Growth Assessment
    Measure height and weight for growth retardation. medlineplus.gov

  7. Rectal Exam
    Detect lower GI masses or bleeding. medlineplus.gov

  8. Neurologic Fundoscopy
    Evaluate for papilledema in intracranial hypertension. medlineplus.gov

Manual Tests

  1. Digital Rectal Examination
    Palpate rectal polyps or masses. medlineplus.gov

  2. Neurologic Sensation Testing
    Assess for focal deficits around brain lesions. medlineplus.gov

  3. Gait Analysis
    Observe coordination issues from cerebellar tumors. medlineplus.gov

  4. Muscle Strength Testing
    Check for hemiparesis from glioma compression. medlineplus.gov

  5. Abdominal Percussion
    Identify organomegaly or fluid accumulation. medlineplus.gov

  6. Palpation of Lymphatic Chains
    Detect lymphoma involvement. medlineplus.gov

  7. Breast and Pelvic Manual Exam
    Screen for early genital tract tumors in adolescents. medlineplus.gov

  8. Muscle Tone Assessment
    Identify spasticity from CNS involvement. medlineplus.gov

Lab and Pathological Tests

  1. Complete Blood Count (CBC)
    Detect anemia, leukocytosis, or blasts in leukemia. medlineplus.gov

  2. Serum Lactate Dehydrogenase (LDH)
    Elevated in lymphoma and other malignancies. medlineplus.gov

  3. CEA and CA 19-9
    Tumor markers for colorectal cancer surveillance. medlineplus.gov

  4. AFP and Beta-hCG
    Screen for germ cell tumors in CMMRD. medlineplus.gov

  5. Bone Marrow Biopsy
    Confirm leukemia subtype and marrow infiltration. medlineplus.gov

  6. Lymph Node Biopsy
    Pathologic diagnosis of lymphoma. medlineplus.gov

  7. Polyp Histology
    Determine dysplasia or carcinoma in colorectal polyps. medlineplus.gov

  8. Immunohistochemistry for MMR Proteins
    Loss of staining for MLH1, MSH2, MSH6, or PMS2 in tumors indicates MMR deficiency. medlineplus.gov

Electrodiagnostic Tests

  1. EEG
    Evaluate seizure focus related to brain tumors. medlineplus.gov

  2. EMG/Nerve Conduction
    Assess peripheral neuropathy from chemotherapy. medlineplus.gov

  3. Somatosensory Evoked Potentials
    Monitor spinal cord function if intramedullary tumors are suspected. medlineplus.gov

  4. Visual Evoked Potentials
    Detect optic pathway involvement by tumor. medlineplus.gov

  5. Brainstem Auditory Evoked Responses
    Screen for brainstem compression. medlineplus.gov

  6. Motor Evoked Potentials
    Evaluate corticospinal tract integrity. medlineplus.gov

  7. Electrocardiogram (ECG)
    Baseline before chemotherapy. medlineplus.gov

  8. Holter Monitor
    Long-term cardiac rhythm monitoring during treatment. medlineplus.gov

Imaging Tests

  1. MRI Brain with Contrast
    Gold standard for detecting gliomas and developmental venous anomalies. medlineplus.gov

  2. CT Abdomen and Pelvis
    Identify colorectal masses and metastatic disease. medlineplus.gov

  3. Colonoscopy
    Direct visualization and removal of polyps. medlineplus.gov

  4. Capsule Endoscopy
    Screen small intestine for polyps or tumors. medlineplus.gov

  5. MRI Spine
    Detect leptomeningeal spread of CNS tumors. medlineplus.gov

  6. Ultrasound Pelvis
    Screen for ovarian and uterine tumors in adolescents. medlineplus.gov

  7. PET–CT
    Assess metabolic activity and staging of malignancies. medlineplus.gov

  8. Chest X-Ray/CT
    Evaluate for pulmonary metastases. medlineplus.gov

Non-Pharmacological Treatments

Physiotherapy and Electrotherapy Therapies 

  1. Manual therapy
    Manual therapy involves hands-on techniques to mobilize joints and soft tissues. It can relieve pain, improve mobility, and reduce muscle stiffness after cancer surgery or during recovery.

  2. Myofascial release therapy
    This therapy reduces tightness and pain in the connective tissue, helping people improve movement and reduce discomfort, especially after abdominal surgeries.

  3. Lymphatic drainage massage
    Used to reduce swelling, especially in patients who have had lymph nodes removed. It helps promote lymph fluid movement and reduce pain.

  4. Neuromuscular electrical stimulation (NMES)
    NMES uses electrical currents to stimulate weak muscles, helping rebuild strength, particularly after long hospital stays.

  5. Transcutaneous electrical nerve stimulation (TENS)
    TENS relieves pain through electrical impulses, blocking pain signals to the brain and promoting natural painkillers called endorphins.

  6. Ultrasound therapy
    Ultrasound waves help promote tissue healing and reduce scar tissue formation, supporting recovery after cancer-related surgeries.

  7. Cryotherapy (cold therapy)
    Reduces inflammation, swelling, and pain, especially in joint areas affected during cancer treatments.

  8. Heat therapy
    Helps relax muscles, improve blood flow, and reduce stiffness.

  9. Balance and gait training
    Focuses on improving stability and preventing falls, especially after chemotherapy, which can affect balance.

  10. Breathing exercises
    Helps improve lung function and reduce stress, especially important after abdominal or thoracic surgeries.

  11. Pelvic floor rehabilitation
    Strengthens pelvic muscles, which may weaken after certain surgeries or treatments affecting the pelvic area.

  12. Scar tissue mobilization
    Helps break down excessive scar tissue and improve skin flexibility.

  13. Postural correction therapy
    Improves spinal alignment and prevents musculoskeletal pain.

  14. Hydrotherapy
    Water-based exercises reduce joint stress and improve mobility, useful for patients with pain or weakness.

  15. Biofeedback therapy
    Teaches control of certain body functions (like muscle tension) to reduce pain and improve function.

Exercise Therapies

  1. Aerobic exercise
    Includes walking, cycling, or swimming to improve cardiovascular health and reduce cancer-related fatigue.

  2. Resistance training
    Uses weights or bands to improve muscle strength, counteracting muscle loss from cancer treatments.

  3. Flexibility exercises
    Stretching routines enhance range of motion and reduce stiffness.

Mind-Body Therapies

  1. Yoga
    Combines physical postures, breathing, and meditation to improve strength, reduce anxiety, and enhance overall well-being.

  2. Tai chi
    A gentle martial art focusing on slow, controlled movements to improve balance, flexibility, and mental calmness.

  3. Meditation and mindfulness
    Reduces stress and anxiety, improving emotional resilience during cancer management.

Educational and Self-Management Interventions

  1. Pain education programs
    Teach patients how to understand and cope with cancer-related pain.

  2. Self-care skill training
    Helps patients learn daily strategies for managing fatigue, diet, and symptoms.

  3. Fatigue management education
    Offers practical advice on conserving energy and balancing activities.

Drugs (Evidence-Based)

  1. Aspirin
    Class: NSAID.
    Dosage: 81–325 mg daily (for chemoprevention).
    Purpose: May reduce colorectal cancer risk.
    Side effects: Stomach irritation, bleeding risk.

  2. 5-Fluorouracil (5-FU)
    Class: Antimetabolite chemotherapy.
    Dosage: Varies by regimen (e.g., continuous infusion or bolus).
    Purpose: Used in colorectal cancer treatment.
    Side effects: Mouth sores, diarrhea, low blood counts.

  3. Capecitabine
    Class: Oral fluoropyrimidine.
    Dosage: Usually 1250 mg/m² twice daily for 14 days in a 21-day cycle.
    Purpose: Alternative to 5-FU.
    Side effects: Hand-foot syndrome, nausea.

  4. Oxaliplatin
    Class: Platinum-based chemotherapy.
    Dosage: Typically 85 mg/m² every 2 weeks.
    Purpose: Combined with 5-FU for advanced disease.
    Side effects: Neuropathy, low blood counts.

  5. Irinotecan
    Class: Topoisomerase inhibitor.
    Dosage: 180 mg/m² every 2 weeks.
    Purpose: Second-line colorectal cancer therapy.
    Side effects: Severe diarrhea, neutropenia.

  6. Bevacizumab
    Class: Anti-VEGF antibody.
    Dosage: 5–10 mg/kg every 2 weeks.
    Purpose: Inhibits tumor blood vessel growth.
    Side effects: Hypertension, bleeding risk.

  7. Cetuximab
    Class: EGFR inhibitor.
    Dosage: 400 mg/m² initial, then 250 mg/m² weekly.
    Purpose: For RAS wild-type tumors.
    Side effects: Skin rash, infusion reactions.

  8. Pembrolizumab
    Class: PD-1 inhibitor immunotherapy.
    Dosage: 200 mg every 3 weeks.
    Purpose: For MMR-deficient tumors.
    Side effects: Fatigue, immune-related side effects.

  9. Nivolumab
    Class: PD-1 inhibitor.
    Dosage: 240 mg every 2 weeks.
    Purpose: Similar to pembrolizumab.
    Side effects: Autoimmune reactions.

  10. Lenvatinib
    Class: Multi-kinase inhibitor.
    Dosage: 20 mg daily.
    Purpose: For advanced endometrial cancer.
    Side effects: Hypertension, fatigue.

  11. Tamoxifen
    Class: Estrogen receptor modulator.
    Dosage: 20 mg daily.
    Purpose: For patients with certain secondary breast cancers.
    Side effects: Hot flashes, clot risk.

  12. Leucovorin
    Class: Folinic acid.
    Dosage: Varies with 5-FU regimens.
    Purpose: Enhances 5-FU effect.
    Side effects: Mild; enhances side effects of 5-FU.

  13. Regorafenib
    Class: Multi-kinase inhibitor.
    Dosage: 160 mg daily for 21 days on/7 days off.
    Purpose: Advanced colorectal cancer.
    Side effects: Fatigue, liver toxicity.

  14. Trifluridine/tipiracil
    Class: Antimetabolite combination.
    Dosage: 35 mg/m² twice daily, days 1-5 and 8-12 in a 28-day cycle.
    Purpose: Late-line colorectal cancer.
    Side effects: Low blood counts, nausea.

  15. Ziv-aflibercept
    Class: VEGF trap.
    Dosage: 4 mg/kg every 2 weeks.
    Purpose: With FOLFIRI regimen.
    Side effects: Hypertension, bleeding.

  16. Ramucirumab
    Class: VEGFR-2 inhibitor.
    Dosage: 8 mg/kg every 2 weeks.
    Purpose: Advanced cancers.
    Side effects: High blood pressure, proteinuria.

  17. Panitumumab
    Class: EGFR inhibitor.
    Dosage: 6 mg/kg every 2 weeks.
    Purpose: Similar to cetuximab.
    Side effects: Skin toxicity.

  18. Aflibercept
    Class: VEGF inhibitor.
    Dosage: 4 mg/kg every 2 weeks.
    Purpose: In combination chemotherapy.
    Side effects: Bleeding, clotting.

  19. Aspirin high-dose
    Class: NSAID (higher dose).
    Dosage: Up to 600 mg daily (investigational for cancer prevention).
    Side effects: Gastrointestinal bleeding.

  20. Lynch-specific vaccines (future research)
    Class: Immunotherapy.
    Dosage: Under investigation.
    Purpose: Potential to prevent tumors.
    Side effects: Not fully known yet.

Dietary Molecular Supplements

  1. Vitamin D
    Dosage: 1,000–2,000 IU daily.
    Function: Supports immune function and may help reduce cancer risk.
    Mechanism: Regulates cell growth and immune modulation.

  2. Calcium
    Dosage: 1,000–1,500 mg daily.
    Function: May lower colorectal cancer risk.
    Mechanism: Binds bile acids, reducing mucosal irritation.

  3. Omega-3 fatty acids
    Dosage: 1,000–2,000 mg daily.
    Function: Reduces inflammation and supports heart health.
    Mechanism: Anti-inflammatory effects.

  4. Curcumin
    Dosage: 500–1,000 mg daily.
    Function: Anti-inflammatory, potential cancer preventive.
    Mechanism: Modulates signaling pathways involved in cell proliferation.

  5. Green tea extract (EGCG)
    Dosage: 300–500 mg daily.
    Function: Antioxidant, may reduce tumor growth.
    Mechanism: Inhibits DNA damage.

  6. Folate
    Dosage: 400–800 mcg daily.
    Function: Supports DNA synthesis and repair.
    Mechanism: Essential in methylation processes.

  7. Selenium
    Dosage: 100–200 mcg daily.
    Function: Antioxidant defense.
    Mechanism: Reduces oxidative stress.

  8. Probiotics
    Dosage: 1–10 billion CFU daily.
    Function: Supports gut health and immunity.
    Mechanism: Modulates gut microbiota.

  9. Resveratrol
    Dosage: 100–250 mg daily.
    Function: Anti-aging and anti-cancer properties.
    Mechanism: Inhibits cancer cell proliferation.

  10. Fiber supplements
    Dosage: 20–30 g daily.
    Function: Promotes bowel health.
    Mechanism: Reduces transit time and dilutes carcinogens.

Additional Drug Therapies

Bisphosphonates

  1. Alendronate
    Dosage: 70 mg weekly.
    Function: Strengthens bones, prevents metastasis-related fractures.
    Mechanism: Inhibits bone resorption.

  2. Zoledronic acid
    Dosage: 4 mg IV every 3–4 weeks.
    Function: Reduces skeletal-related events.
    Mechanism: Strong osteoclast inhibition.

Regenerative and Stem Cell Drugs

  1. Mesenchymal stem cells (experimental)
    Dosage: Varies in trials.
    Function: Tissue regeneration.
    Mechanism: Differentiates into multiple cell types.

  2. Hematopoietic stem cells
    Dosage: Individualized.
    Function: Restores blood cells after intensive chemo.
    Mechanism: Replaces damaged marrow.

Viscosupplementations

  1. Hyaluronic acid injections
    Dosage: Weekly for 3–5 weeks.
    Function: Joint lubrication.
    Mechanism: Improves synovial fluid quality.

  2. Platelet-rich plasma (PRP)
    Dosage: Typically 1–3 injections.
    Function: Accelerates healing.
    Mechanism: Growth factor release.

  3. Stem cell-conditioned media
    Dosage: Under research.
    Function: Promotes repair.
    Mechanism: Paracrine signaling.

Other Regenerative Drugs

  1. Bone morphogenetic proteins
    Dosage: Local application in surgery.
    Function: Stimulates bone growth.
    Mechanism: Osteoinduction.

  2. Synthetic peptide gels
    Dosage: Depends on application.
    Function: Promotes wound healing.
    Mechanism: Cellular migration support.

  3. Growth factor concentrates
    Dosage: Localized application.
    Function: Tissue regeneration.
    Mechanism: Stimulates repair pathways.

Surgeries

  1. Colectomy
    Procedure: Removes part or all of the colon.
    Benefits: Reduces colorectal cancer risk.

  2. Prophylactic hysterectomy
    Procedure: Removes the uterus.
    Benefits: Prevents endometrial cancer.

  3. Bilateral salpingo-oophorectomy
    Procedure: Removes ovaries and fallopian tubes.
    Benefits: Prevents ovarian cancer.

  4. Polypectomy
    Procedure: Removes colon polyps during colonoscopy.
    Benefits: Prevents progression to cancer.

  5. Segmental bowel resection
    Procedure: Removes cancerous bowel sections.
    Benefits: Cancer removal, preserves bowel function.

  6. Liver metastasectomy
    Procedure: Removes liver metastases.
    Benefits: Improves survival.

  7. Lymph node dissection
    Procedure: Removes regional lymph nodes.
    Benefits: Stages cancer and prevents spread.

  8. Hepatic artery infusion pump placement
    Procedure: Delivers chemotherapy directly to liver.
    Benefits: Higher local drug concentration.

  9. Pelvic exenteration
    Procedure: Removes pelvic organs in advanced cancer.
    Benefits: Last resort curative option.

  10. Minimally invasive laparoscopic surgery
    Procedure: Uses small incisions and a camera.
    Benefits: Less pain, faster recovery.

Prevention Tips

  1. Regular colonoscopy screenings
    Detect polyps early and remove them before cancer develops.

  2. Genetic counseling
    Identify at-risk family members and plan surveillance.

  3. Healthy diet
    Rich in vegetables, whole grains, and fiber reduces risk.

  4. Regular physical activity
    Keeps weight healthy and reduces inflammation.

  5. Avoid smoking
    Smoking increases various cancer risks.

  6. Limit alcohol consumption
    Excess alcohol can promote cancer development.

  7. Maintain a healthy weight
    Obesity is a known cancer risk factor.

  8. Use of aspirin (under doctor advice)
    Reduces polyp formation.

  9. Manage chronic conditions
    Diabetes and inflammatory bowel disease may elevate risk.

  10. Regular gynecological exams
    Essential for women to detect endometrial changes early.

When to See a Doctor

Seek immediate medical advice if you have unexplained weight loss, blood in stool, persistent abdominal pain, prolonged fatigue, or changes in bowel habits. Early detection saves lives.

What to Do and What to Avoid

What to Do

  1. Follow recommended screening schedules.

  2. Eat a balanced diet.

  3. Stay physically active.

  4. Adhere to medical advice and medication.

  5. Attend genetic counseling.

  6. Monitor for new symptoms.

  7. Maintain hydration.

  8. Join support groups.

  9. Use stress-reduction techniques.

  10. Stay updated on new research.

What to Avoid

  1. Ignoring family history.

  2. Smoking.

  3. Excessive alcohol.

  4. Processed meats in large amounts.

  5. Self-medicating.

  6. Ignoring regular check-ups.

  7. Sedentary lifestyle.

  8. Crash dieting.

  9. Overusing supplements without guidance.

  10. Delaying medical care for new symptoms.

Frequently Asked Questions (FAQs)

  1. What is mismatch repair cancer syndrome?
    It is a genetic condition that increases cancer risk due to defective DNA repair.

  2. Is it the same as Lynch syndrome?
    Yes, Lynch syndrome is the most common type of MMR syndrome.

  3. What cancers are most common?
    Colorectal and endometrial cancers.

  4. How is it inherited?
    Autosomal dominant—one mutated gene from either parent.

  5. Can it be prevented?
    While not fully preventable, regular screenings and surgeries reduce risk.

  6. Is genetic testing necessary?
    Yes, especially if there’s a strong family history.

  7. When should screening start?
    Often from age 20–25 or 2–5 years before the earliest family cancer.

  8. What if I test positive?
    You’ll follow a personalized surveillance and prevention plan.

  9. Are there lifestyle changes that help?
    Yes—healthy diet, exercise, and no smoking.

  10. Is there a cure?
    No cure for the genetic mutation, but cancers can be treated or prevented.

  11. What treatments are available?
    Surgery, chemotherapy, targeted drugs, immunotherapy.

  12. Does insurance cover genetic testing?
    Often yes, depending on guidelines and risk.

  13. Can men also get it?
    Yes, men can develop colorectal and other cancers.

  14. Can I have children?
    Yes, but genetic counseling is advised.

  15. Will I definitely get cancer?
    No, but your risk is significantly higher.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 04, 2025.

Doctor visit helper

Prepare before seeing a doctor

A simple rural-patient checklist to help you explain symptoms clearly, ask better questions, and avoid unsafe self-treatment.

Safety note: This is not a prescription or diagnosis. For severe symptoms, pregnancy danger signs, children with serious illness, chest pain, breathing difficulty, stroke-like weakness, or major injury, seek urgent care.

Which doctor may help?

Start with a registered doctor or the nearest qualified health center.

What to tell the doctor

  • Write when the problem started and how it changed.
  • Bring old prescriptions, investigation reports, and current medicines.
  • Write allergies, pregnancy status, diabetes, kidney/liver disease, and major past illnesses.
  • Bring one family member if the patient is weak, elderly, confused, or a child.

Questions to ask

  • What is the most likely cause of my symptoms?
  • Which danger signs mean I should go to hospital quickly?
  • Which tests are necessary now, and which can wait?
  • How should I take medicines safely and what side effects should I watch for?
  • When should I come for follow-up?

Tests to discuss

  • Vital signs: temperature, pulse, blood pressure, oxygen saturation
  • Basic physical examination by a clinician
  • CBC, urine test, blood sugar, or imaging only when clinically needed

Avoid these mistakes

  • Do not use antibiotics, steroid tablets/injections, or strong painkillers without proper medical advice.
  • Do not hide pregnancy, kidney disease, ulcer, allergy, or blood thinner use.
  • Do not delay emergency care when danger signs are present.

Medicine safety and first-aid guide

This section is for patient education only. It does not replace a doctor, pharmacist, or emergency care.

Safe first steps

  • Avoid heavy lifting, sudden bending, and prolonged bed rest.
  • Use comfortable posture and gentle movement as tolerated.
  • Discuss physiotherapy, X-ray, or MRI only when clinically needed.

OTC medicine safety

  • For mild back pain, pain-relief medicine may be discussed with a doctor or pharmacist.
  • Avoid repeated painkiller use if you have kidney disease, stomach ulcer, uncontrolled blood pressure, or are taking blood thinners.

Avoid these mistakes

  • Do not start antibiotics without a proper medical decision.
  • Do not use steroid tablets or injections casually for quick relief.
  • Do not delay emergency care because of home remedies.

Get urgent help if

  • Back pain with leg weakness, numbness around private area, loss of urine/stool control, fever, cancer history, or major injury needs urgent care.
Medicine names, dose, and timing must be decided by a qualified clinician or pharmacist after checking age, pregnancy, allergy, other diseases, and current medicines.

For rural patients and family caregivers

Patient health record and symptom diary

Write your symptoms, medicines already taken, test results, and questions before visiting a doctor. This note stays on your device unless you print or copy it.

Doctor to discuss: Orthopedic / spine specialist, physical medicine doctor, or qualified clinician
Tests to discuss with doctor
  • Neurological examination for leg power, sensation, reflexes, and straight leg raise
  • X-ray only if injury, deformity, long-lasting pain, or doctor suspects bone problem
  • MRI discussion if severe nerve symptoms, weakness, bladder/bowel problem, or persistent symptoms
Questions to ask
  • What is the most likely cause of my symptoms?
  • Which warning signs mean I should go to emergency care?
  • Which tests are really needed now?
  • Which medicines are safe for my age, pregnancy status, allergy, kidney/liver/stomach condition, and current medicines?
  • Is physiotherapy, posture correction, or activity modification needed?

Emergency warning signs such as chest pain, severe breathing difficulty, sudden weakness, confusion, severe dehydration, major injury, or loss of bladder/bowel control need urgent medical care. Do not wait for online information.

Safe pathway to proper treatment

Care roadmap for: Mismatch Repair Cancer Syndrome

Use this simple roadmap to understand the next safe steps. It is educational and does not replace examination by a doctor.

Go to emergency care if you notice:
  • Severe or rapidly worsening symptoms
  • Breathing difficulty, chest pain, fainting, confusion, severe weakness, major injury, or severe dehydration
Doctor / service to discuss: Qualified healthcare provider; specialist depends on symptoms and examination.
  1. Step 1

    Check danger signs first

    If danger signs are present, seek emergency care and do not wait for online information.

  2. Step 2

    Record the symptom story

    Write when symptoms started, severity, medicines already taken, allergies, pregnancy status, and test results.

  3. Step 3

    Visit a qualified clinician

    A doctor, nurse, or qualified healthcare provider can examine you and decide which tests or treatment are needed.

  4. Step 4

    Do only useful tests

    Do tests after clinical assessment. Avoid unnecessary tests, random antibiotics, or repeated medicines without diagnosis.

  5. Step 5

    Follow up and return early if worse

    If symptoms worsen, new warning signs appear, or treatment is not helping, return for review quickly.

Rural patient practical tips
  • Take a written symptom diary and all previous prescriptions/test reports.
  • Do not hide medicines already taken, even herbal or over-the-counter medicines.
  • Ask which warning signs mean urgent referral to hospital.

This roadmap is for education. A real diagnosis and treatment plan requires history, examination, and clinical judgment.

RX Patient Help

Ask a health question safely

Write your symptom story. A health professional or site editor can review it before any answer is prepared. This box is not for emergency care.

Emergency first: Severe chest pain, breathing trouble, unconsciousness, stroke signs, severe injury, heavy bleeding, or rapidly worsening symptoms need urgent local medical care now.

Frequently Asked Questions

Is this article a replacement for a doctor?

No. It is educational content only. Patients should consult a qualified clinician for diagnosis and treatment.

When should I seek urgent care?

Seek urgent care for severe symptoms, rapidly worsening condition, breathing difficulty, severe pain, neurological changes, or any emergency warning sign.

References

Add references, clinical guidelines, textbooks, journal articles, or trusted medical sources here. You can edit this area from the RX Article Professional Blocks panel.

More from this topic
  1. Congenital Enterocyte Heparan Sulfate Deficiency

    DefinitionCongenital? enterocyte heparan sulfate deficiency is a very rare, severe, genetic intestinal disease. In this condition, the small bowel lining cells, called enterocytes, do not show...

    April 3, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  2. Congenital ectropion uveae

    DefinitionCongenital? ectropion uveae, often shortened to CEU, is a very rare eye condition present from birth. In this condition, the dark pigment layer that normally stays...

    April 2, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  3. Congenital Dyserythropoietic Anemia, Type III

    DefinitionCongenital? dyserythropoietic anemia?, type III, also called CDA type III, is a very rare inherited blood disease. In this disease, the bone marrow tries to make...

    April 2, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  4. Congenital Dyserythropoietic Anemia Type I

    DefinitionCongenital? dyserythropoietic anemia?, type I, usually called CDA type I, is a rare inherited blood disease. In this disease, the bone marrow tries to make red...

    April 1, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  5. Congenital Dyserythropoietic Anemia Due to KLF1 Mutation

    DefinitionCongenital? dyserythropoietic anemia? due to KLF1 mutation is a very rare inherited red blood cell disease. In most reported cases, doctors describe it as congenital? dyserythropoietic...

    April 1, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  6. Congenital Dyserythropoietic Anemia Due to KLF1 Mutation

    DefinitionCongenital? dyserythropoietic anemia? due to KLF1 mutation is a very rare inherited red blood cell disease. In most reported cases, doctors describe it as congenital? dyserythropoietic...

    April 1, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  7. HEMPAS – Hereditary Erythroblast Multinuclearity with Positive Acid Serum Test

    DefinitionHEMPAS – Hereditary Erythroblast Multinuclearity with Positive Acid Serum Test is a rare inherited blood disease. Its full old name is hereditary erythroblastic multinuclearity with positive...

    April 1, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  8. Congenital Dyserythropoietic Anemia Type 2

    DefinitionCongenital? dyserythropoietic anemia? type 2, also called CDA type II, is a rare inherited blood disease. In this disease, the body makes red blood cells in...

    April 1, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  9. Component of Oligomeric Golgi Complex 2–Congenital Disorder of Glycosylation

    DefinitionComponent of oligomeric Golgi complex 2–congenital? disorder of glycosylation is usually called COG2-CDG. It is a very rare inherited metabolic disease. In this disease, both copies...

    April 1, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  10. Congenital Disorder of Glycosylation, Type IIq

    DefinitionCongenital? disorder of glycosylation, type IIq, is a very rare inherited metabolic disease. It is now also commonly called COG2-CDG because it is caused by harmful...

    April 1, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)